Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 ASHP Guidelines on Pharmacist Involvement in HIV Care.

Literature DB >> 26892679

ASHP Guidelines on Pharmacist Involvement in HIV Care.

Jason J Schafer¹, Taylor K Gill², Elizabeth M Sherman³, Ian R McNicholl⁴.

Abstract

Mesh：

Year: 2016 PMID： 26892679 DOI： 10.2146/ajhp150623

Source DB: PubMed Journal: Am J Health Syst Pharm ISSN： 1079-2082 Impact factor: 2.637

Keyword Cloud
Cited

× No keyword cloud information.

14 in total

1. Using Hand Signs to Teach HIV Medications.

Authors: Catherine Spencer; Kathryn Bandy
Journal: Am J Pharm Educ Date: 2018-02 Impact factor: 2.047

2. Clinical Impact of the Capacity-Motivation-Opportunity Pharmacist-Led Intervention in People Living with HIV in Spain, 2019-2020.

Authors: Ramón Morillo-Verdugo; María de Las Aguas Robustillo-Cortes; Andrés Navarro-Ruiz; Javier Sánchez-Rubio Ferrandez; Sergio Fernández Espínola; María Fernández-Pacheco García-Valdecasas; Manuel Vélez-Diaz-Pallares
Journal: J Multidiscip Healthc Date: 2022-05-24

3. Student Education About Pre-exposure Prophylaxis (PrEP) Varies Between Regions of the United States.

Authors: Samuel R Bunting; Sarah S Garber; Robert H Goldstein; Timothy D Ritchie; Tamzin J Batteson; Timothy J Keyes
Journal: J Gen Intern Med Date: 2020-02-20 Impact factor: 5.128

4. Patient satisfaction with chronic HIV care provided through an innovative pharmacist/nurse-managed clinic and a multidisciplinary clinic.

Authors: Jason Kielly; Deborah V Kelly; Shabnam Asghari; Kim Burt; Jessica Biggin
Journal: Can Pharm J (Ott) Date: 2017-10-06

5. Impact and acceptance of pharmacist-led interventions during HIV care in a third-level hospital in Spain using the Capacity-Motivation-Opportunity pharmaceutical care model: the IRAFE study.

Authors: M Gracia Cantillana-Suárez; Maria de Las Aguas Robustillo-Cortés; Antonio Gutiérrez-Pizarraya; Ramón Morillo-Verdugo
Journal: Eur J Hosp Pharm Date: 2021-02-24

10. Satisfaction and knowledge among patients with HIV after switching from tenofovir to tenofovir alafenamide in regimens containing emtricitabine and rilpivirine

Authors: Manuel Vélez-Díaz-Pallarés; Teresa Gramage-Caro; Miguel Ángel Rodríguez-Sagrado; Beatriz Montero-Llorente; Teresa Bermejo-Vicedo
Journal: Biomedica Date: 2020-05-01 Impact factor: 0.935

ASHP Guidelines on Pharmacist Involvement in HIV Care.

1. Using Hand Signs to Teach HIV Medications.

2. Clinical Impact of the Capacity-Motivation-Opportunity Pharmacist-Led Intervention in People Living with HIV in Spain, 2019-2020.

3. Student Education About Pre-exposure Prophylaxis (PrEP) Varies Between Regions of the United States.

4. Patient satisfaction with chronic HIV care provided through an innovative pharmacist/nurse-managed clinic and a multidisciplinary clinic.

5. Impact and acceptance of pharmacist-led interventions during HIV care in a third-level hospital in Spain using the Capacity-Motivation-Opportunity pharmaceutical care model: the IRAFE study.

6. Assessing the Effects of a Paired TBL Session and Patient Simulation on Pharmacy Student HIV Treatment Knowledge.

7. Importance of pharmacist-patient relationship in people living with HIV and concomitant opioid use disorder.

Review 8. The economic impact of pharmacist care for people living with HIV/AIDS: A systematic review.

9. A pharmacist-led medication switch protocol in an academic HIV clinic: patient knowledge and satisfaction.

10. Satisfaction and knowledge among patients with HIV after switching from tenofovir to tenofovir alafenamide in regimens containing emtricitabine and rilpivirine